Potential Risks and Benefits of Gain-of-Function Research Summary of a Workshop (2015) / Chapter Skim
Currently Skimming:
Appendix D: Speaker Biographies
Appendix D: Speaker Biographies
Pages 103-116
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 103... ...
Dr. Briese was responsible for cloning the genome of Borna disease virus, a novel infectious agent potentially linked to some mental disorders.
|
From page 104... ...
Dr. Denison's lab team uses targeted reverse genetic mutagenesis and adaptive experimental evolution to define key determinants of coronavirus replication fidelity and its impact on pathogenesis, adaptation, and inhibition.
|
From page 105... ...
Fineberg -- please see committee biographies Baruch Fischhoff -- please see committee biographies Christophe Fraser is currently Chair of Theoretical Epidemiology and Royal Society University Research Fellow at Imperial College London. He trained in theoretical particle physics, obtaining his PhD in 1997, and shifted areas to infectious disease epidemiology in 1998, training under Roy Anderson.
|
From page 106... ...
He completed his doctoral work in the laboratory of C David Pauza at the University of Maryland, Baltimore, where he focused on understanding an unconventional lymphocyte population that is important during immune responses to infectious disease and cancer.
|
From page 107... ...
Jude, Dr. Kawaoka established an independent program to address such fundamental questions in influenza virology as how do influenza viruses cause disease; why are certain types of influenza viruses found in humans while other types are found only in birds; and how do influenza viruses change over time.
|
From page 108... ...
Kawaoka regarding the attenuation of deadly influenza viruses -- was exploited in the development of candidate H5N1 influenza virus vaccines, which were proven efficacious in clinical trials.
|
From page 109... ...
Gregory Koblentz is an Associate Professor in the School of Policy, Government, and International Affairs and Deputy Director of the Biodefense Graduate Program at George Mason University. He is also a Research Affiliate with the Security Studies Program at the Massachusetts Institute of Technology, Associate Faculty at the Center for Global Studies at George Mason, and a member of the Scientist Working Group on Chemical and Biological Weapons at the Center for Arms Control and Non-Proliferation in Washington, DC.
|
From page 110... ...
Her duties include oversight of advanced development and acquisition programs for Project BioShield medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats as well as pandemic influenza vaccines, drugs, diagnostics, and infrastructure.
|
From page 111... ...
His team at CCDD played a leading role in the analysis and response to the 2009 influenza A/H1N1 pandemic, working closely with local, state, national, and international public health agencies. In addition to ongoing studies of pandemic and seasonal influenza burden, preparedness, and response, current research includes the application of population genomics to understand the spread of infections and the changes produced in bacterial population by human immunity, and modeling the effects of pneumococcal vaccination.
|
From page 112... ...
She is also a lead member of the UW-Madison Biosecurity Task Force, consisting of a diverse body of experts from across campus and responsible for regularly reviewing the research programs and practices of its Select Agent researchers. She is a certified biosafety professional with the American Biological Safety Association (ABSA)
|
From page 113... ...
Monica Schoch-Spana, a medical anthropologist, is a senior associate with the UPMC Center for Health Security, an Associate Professor of Anthropology at the Texas State University, and a former Associate Professor of Medicine at the University of Pittsburgh. Her research and policy interests include disaster resilience, community engagement, public health emergency preparedness, and nuclear incident preparedness, response, and recovery.
|
From page 114... ...
These studies led to a faculty position at the Southeast Poultry Research Lab (USDA-ARS) studying HPAI.
|
From page 115... ...
After postdoctoral training in the Laboratory of Infectious Diseases (LID) at the National Institutes of Health, she served on the faculty at McGill University, Montreal, Canada, and subsequently served as Chief of the Molecular Genetics Section of the Influenza Branch at the Centers for Disease Control and Prevention.
|
From page 116... ...
Rob Weyant currently serves as the Director of the Division of Select Agents and Toxins, Office of Public Health Preparedness and Emergency Response, CDC (DSAT)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.